By Iain Gilbert
Date: Wednesday 01 Jul 2020
LONDON (ShareCast) - (Sharecast News) - Antibodies developer Bioventix named Bruce Hiscock would join the group its new chief financial officer on Wednesday.
Hiscock, previously chief executive and CFO of everyLIFE Technologies, a technology business delivering digital care planning solutions to social care providers, will start in the role with immediate effect.
The AIM-listed group highlighted that Hiscock had held several CFO roles at both fast-growing listed and private companies over his 30-year career and was a member of the Institute of Chartered Accountants of Scotland.
As of 0940 BST, Bioventix shares were up 1.20% at 4,200p.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 4,475.00p |
Change Today | -50.00p |
% Change | -1.11 % |
52 Week High | 5,060.00 |
52 Week Low | 3,500.00 |
Volume | 1,079 |
Shares Issued | 5.22m |
Market Cap | £233.58m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Latest | Previous | |
---|---|---|
1st Interim | 2nd Interim | |
Ex-Div | 11-Apr-24 | 09-Nov-23 |
Paid | 26-Apr-24 | 24-Nov-23 |
Amount | 68.00p | 90.00p |
Time | Volume / Share Price |
16:16 | 98 @ 4,450.00p |
16:14 | 44 @ 4,480.00p |
14:26 | 100 @ 4,485.00p |
14:16 | 245 @ 4,487.00p |
14:00 | 340 @ 4,489.00p |
CEO | Peter John Harrison |
Chair | Ian James Nicholson |
CFO | Bruce Hiscock |
You are here: research